Systematic review of outcomes and patient heterogeneity in relapsed or refractory diffuse large B-cell lymphoma

AIM: To evaluate trials of systemic therapies in transplant-ineligible or -experienced, relapsed/refractory diffuse large-B cell lymphoma and the impact of patient characteristics on overall response rate (ORR). PATIENTS & METHODS: Systematically reviewed multiple databases through 22 July 2021....

Descripción completa

Detalles Bibliográficos
Autores principales: Miller, Sally D, Lozano-Ortega, Greta, Mutebi, Alex, Briggs, Owanate, Sail, Kavita, Elliott, Brian, Kalsekar, Anupama
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Becaris Publishing Ltd 2022
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10288944/
https://www.ncbi.nlm.nih.gov/pubmed/36417238
http://dx.doi.org/10.2217/cer-2022-0146

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10288944/
https://www.ncbi.nlm.nih.gov/pubmed/36417238
http://dx.doi.org/10.2217/cer-2022-0146

Ejemplares similares